Skip to main content
Figure 6 | Molecular Cancer

Figure 6

From: The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells

Figure 6

Enhanced activities of Zt/f2 and 5FU in inhibition of tumor growth. HT-29 cell-mediated tumor growth in athymic nude mice was used as the model (O'Toole et al., 2006). Zt/f2 treatment began when tumor volumes reached about 9 mm3 (around 8 days after cell inoculation). A) Comparison of tumor weights from different groups of G-I. B) Survival rates in different groups of G-II. In both G-I and G-II, statistical significance (p < 0.05) is indicated with a star.

Back to article page

Molecular Cancer

ISSN: 1476-4598